Catalog: | C-FC-3642A |
Product Type: | FCM Antibody |
Size: | 25 Tests/100 Tests |
Concentration: | 5 μl/Test, 0.1 mg/ml |
Reactivity: | Human |
Specificity: | Human Carbonic Anhydrase IX |
Analysis mode: | FCM |
Host: | Rabbit |
Clonality: | Monoclonal |
Isotype: | IgG |
Alternate names: | carbonic anhydrase IX |
Form: | Liquid |
Shipping: | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Storage: | This antibody can be stored at 2℃-8℃ for twelve months without detectable loss of activity. Protected from prolonged exposure to light. Do not freeze ! Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal. |
Purification method: | Protein A |
Conjugation: | PE |
Immunogen: | Recombinant Human Carbonic Anhydrase IX/CA9 Protein |
Buffer: | Aqueous solution containing 0.5% BSA and 0.09% sodium azide |
Application: | Cancer Drug Targets |
Carbonic anhydrases IX (CA IX), also known as membrane antigen MN or CA9, is a member of the carbonic anhydrase (CA) family and may be involved in cell proliferation and cellular transformation. CAs are zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide (H2O + CO2 = H+ + HCO3–) and thus participate in a variety of biological and physical processes. CA IX protein is expressed primarily in carcinoma cells lines, and the expression is cell density dependent and has been shown to be strongly induced by hypoxia, accordingly facilitates adaptation of tumor cells to hypoxic conditions. It is involved in tumorigenesis through many pathways, such as pH regulation and cell adhesion control. CA IX is used as a marker of tumor hypoxia and as a new therapeutic target for many human carcinomas and cancers.
Copyright © 2025 Creative Biogene. All rights reserved.